login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GENOMIC HEALTH INC (GHDX) Stock News
USA
- NASDAQ:GHDX -
63.44
-0.44 (-0.69%)
Last: 11/7/2019, 8:00:01 PM
63.44
0 (0%)
After Hours:
11/7/2019, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GHDX Latest News, Press Relases and Analysis
All
Press Releases
6 years ago - By: Zacks Investment Research
Why the Earnings Surprise Streak Could Continue for Genomic Health (GHDX)
6 years ago - By: EXACT SCIENCES CORP
- Mentions:
EXAS
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company
6 years ago - By: Genomic Health, Inc.
- Mentions:
EXAS
Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences
6 years ago - By: Analyst Ratings
- Mentions:
RARE
JPM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Genomic Health (NASDAQ: GHDX)
6 years ago - By: Seeking Alpha
- Mentions:
SHEN
Shentel set to join SmallCap 600
6 years ago - By: Seeking Alpha
Genomic Health reported EPS beat of $0.10
6 years ago - By: StockNews.com
- Mentions:
PCG
IPHI
AXE
TENB
...
Best & Worst Performing Mid Cap Stocks for October 30, 2019
6 years ago - By: Seeking Alpha
- Mentions:
MAT
GDOT
PSMT
IPHI
...
ENPH, MAT, CHRW and AJRD among after hour movers
6 years ago - By: Zacks Investment Research
Genomic Health (GHDX) Earnings Expected to Grow: Should You Buy?
6 years ago - By: Zacks Investment Research
- Mentions:
AMGN
GILD
EXAS
Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store?
6 years ago - By: Benzinga
- Mentions:
AKRX
BBBY
GLUU
GPOR
...
25 Stocks Moving in Tuesday's Pre-Market Session
6 years ago - By: The Motley Fool
- Mentions:
NEO
NVTA
Here's Why Genetic Testing Stocks Tumbled in September
6 years ago - By: InvestorPlace
- Mentions:
BMY
CELG
EXAC
BLUE
...
3 Cancer-Fighting Drug Stocks to Buy Right Now
6 years ago - By: Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Genomic Health, Inc. (GHDX)
6 years ago - By: Genomic Health, Inc.
New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence ScoreĀ® Test to Guide Chemotherapy Treatment
6 years ago - By: Zacks Investment Research
- Mentions:
TRHC
ISRG
DXCM
TDOC
Stocks & ETF to Invest in Healthcare Robotics and Innovation
6 years ago - By: Zacks Investment Research
- Mentions:
PFE
EXAS
GH
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
6 years ago - By: Zacks Investment Research
- Mentions:
TRHC
ISRG
DXCM
TDOC
Stocks & ETF to Invest in Healthcare Robotics and Innovation
6 years ago - By: InvestorPlace
- Mentions:
GOOG
ULTA
CPRT
MSFT
...
10 Excellent Stocks to Watch for 2020 and Beyond
6 years ago - By: Halper Sadeh LLP
- Mentions:
NCI
TYPE
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - GHDX, NCI, TYPE
6 years ago - By: Halper Sadeh LLP
- Mentions:
MCRN
SRCI
SHAREHOLDER ALERT: HALPER SADEH LLP CONTINUES TO INVESTIGATE WHETHER THE SALE OF THESE COMPANIES IS FAIR TO SHAREHOLDERS - MCRN, SRCI, GHDX
6 years ago - By: Zacks Investment Research
Why Is Genomic Health (GHDX) Down 0.5% Since Last Earnings Report?
6 years ago - By: Zacks Investment Research
- Mentions:
BAX
NUVA
MDT
Genomic Health Test to Guide Chemo Per New Breast Cancer Rule
6 years ago - By: Genomic Health, Inc.
New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence ScoreĀ® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer
6 years ago - By: The Motley Fool
- Mentions:
NVS
EXAS
A Breach of Trust? Here's Why the FDA's Taking Aim at Novartis' AveXis
Please enable JavaScript to continue using this application.